These results indicated that the downregulation of Myo10 is responsible for the therapeutic action of KDIP on colorectal tumours with higher KITENIN expression through a disintegration of the KITENIN dimer and thereby a degradation of KITENIN protein. The gene discussed is VANGL1; the disease is colorectal neoplasm.